Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Syros Pharmaceuticals Inc.

www.syros.com

Latest From Syros Pharmaceuticals Inc.

Finance Watch: NGM Bio Is Second NASH IPO In Two Weeks

Public Company Edition: NGM went public a week after Genfit, but endured a rockier start, trading below its IPO price. Also, Blueprint, Tricida and Sangamo launch large offerings after positive clinical and regulatory updates.

Financing Business Strategies

Syros’ 98% Solution For Genomic Medicine

Emerging Company Profile: Coming off its first partnership and a $43.2m IPO, Syros looks ahead to data later this year for its first two clinical candidates, both first-in-class agents that regulate gene expression.

Business Strategies StartUps and SMEs

Appointments: Roche, Eli Lilly, Ipsen And Syros Make New Leadership Hires, Plus Board Appointments At EUSA, Autolus And Forendo

The latest biopharma industry personnel moves include a new executive hires at Roche, Lilly Oncology, Ipsen and Syros, a resignation at Five Prime, plus new board appointments at EUSA, Autolus and Forendo. 

Appointments BioPharmaceutical

Scrip Asks… What Are The Biggest Barriers To Women In Leadership Roles?

Scrip talked to five female CEOs about the barriers in biopharma that prevent more women from reaching the top leadership ranks and their thoughts on what industry can do to improve gender diversity. 

Business Strategies Leadership
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
      • Genomics-Proteomics
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Syros Pharmaceuticals Inc.
  • Senior Management
  • Nancy Simonian, MD, Pres. & CEO
    Joseph F Ferra, CFO
    Eric R Olson, PhD, CSO
    David A Roth, MD, CMO
    Jeremy P Springhorn, PhD, CBO
  • Contact Info
  • Syros Pharmaceuticals Inc.
    Phone: (617) 744-1340
    620 Memorial Dr.
    Ste. 300
    Cambridge, MA 02139
    USA
UsernamePublicRestriction

Register